Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

About this Publication
Title
Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Pubmed ID
11189691 (View this publication on the PubMed website)
Publication
Control Clin Trials. 2000 Dec; Volume 21 (Issue 6 Suppl): Pages 400S-406S
Authors
Miller AB, Yurgalevitch S, Weissfeld JL, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Affiliations
  • Division of Clinical Epidemiology, Deutsches Krebsforschungszentrum, Heidelberg, Germany.
Abstract

The procedures that have been adopted in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial are described. These procedures have been designed to ensure unbiased decisions on the underlying cause of death for all confirmed or suspected PLCO cancers. A death review committee with a nonvoting chair and three experienced reviewers as members has been appointed. After an initial pilot study, the procedures have been instituted and are working well.

Related CDAS Studies